Back to search

United States· US:61703-325_d1f55dd9-cc5b-4162-81be-53736ffbb5a7

Pamidronate Disodium

A medicinal product containing pamidronate disodium, registered in United States by Hospira, Inc..

US label

Checked against FDA National Drug Code directory (United States) on

Informational only — not a medical device.

SOURCE REGISTER · USFDA National Drug Code directory (Unite…normalisedPamidronate DisodiumATC—REGISTER NO.US:61703-325_d1f55dd9…PACKS LISTED2CHECKEDSeptember 27, 2026

The record

At a glance

FDA National Drug Code directory (United States)
Active substance
PAMIDRONATE DISODIUM
Manufacturer
Hospira, Inc.
Country
United States (US)
ATC code
—
Reimbursed
Not published by this register
Source register
FDA National Drug Code directory (United States)
Last checked
September 27, 2026

Packs & prices · 2

  • ndc11
    6170332518
    1 VIAL, SINGLE-DOSE in 1 CARTON (61703-325-18) / 10 mL in 1 VIAL, SINGLE-DOSE
  • ndc11
    61703-325-18

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Same medicine, other countries

Pamidronate disodium in 7 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All pamidronate disodium products

Authorised across Europe · EMA

The same active substance is authorised in 16 EEA countries. Names it is sold under:

  • Austria · Pamidronat Dinatrium Pfizer
  • Belgium · Pamidronaatdinatrium Hospira, Pamidronat-Dinatrium Hospira
  • Czechia · Pamidronate Medac
  • Germany · Pamidro-Cell, Pamidronat Onkovis
  • Denmark · Pamifos
  • Spain · Pamidronato Hospira
  • Finland · Pamifos
  • United Kingdom (Northern Ireland) · Disodium Pamidronate Medac, Disodium Pamidronate Wockhardt Uk
  • Ireland · Disodium Pamidronate Pinewood Laboratories
  • Luxembourg · Pamidronat-Dinatrium Hospira, Pamidronate Disodique Hospira
  • Malta · Pamidronate Disodium Hospira
  • Netherlands · Pamidronaatdinatrium Hospira, Pamipro
  • Poland · Pamifos
  • Portugal · Pamidran, Pamidronato Azevedos
  • Sweden · Pamifos
  • Slovakia · Pamifos

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FDA National Drug Code directory (United States). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/c529aa59-b011-4b46-85de-c82f86a79237
GET /v1/drugs/c529aa59-b011-4b46-85de-c82f86a79237?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "route": "INTRAVENOUS",
  "source": "ndc",
  "strength": "6",
  "substance": "PAMIDRONATE DISODIUM",
  "productndc": "61703-325",
  "dosage_form": "INJECTION, SOLUTION",
  "dea_schedule": null,
  "strength_unit": "mg/mL",
  "application_number": "ANDA075841",
  "marketing_category": "ANDA"
}

See everything about pamidronate disodium.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.